Research Methodology on Allergic Rhinitis Market
1. Introduction:
Allergic rhinitis is a condition of the upper airways that is induced by the inhalation of an allergen, leading to inflammation and an overreaction by the immune system. It is a highly prevalent condition, ranked 6th in the world in terms of disability caused by it. The prevalence of allergic rhinitis is increasing, especially in developing countries due to a sedentary lifestyle, increase in air pollution, presence of allergens in the environment, and changes in climate that favour the expansion of allergic populations.
The market for allergic rhinitis is expected to grow significantly over the forecast period of 2023 to 2030.
2. Research Aim & Objectives:
This research aims to gain an in-depth understanding of the global allergic rhinitis market and provide a market analysis of the market. The specific objectives to achieve this goal are:
iii. Identifying the current trends and types of treatments for allergic rhinitis.
3. Research Hypothesis:
The global market for allergic rhinitis is expected to show strong growth during the forecast period due to the increased prevalence of allergic rhinitis and increased demand for effective treatments.
4. Research Design:
This research project uses a descriptive research design. It is a type of research study that is used to describe and record information regarding the research topic.
5. Sample population and Sampling Strategy:
The target audience for this research project include professionals in the healthcare industry who are involved in the diagnosis, treatment, and management of allergic rhinitis. Furthermore, the sample size and population include patients suffering from allergic rhinitis. The sampling strategy is a non-probability sampling method. Data will be collected from online databases, and literature reviews.
6. Data Collection and Analysis Methods:
The data collection method for this research includes both primary and secondary sources. Primary data is collected through interviews and surveys of healthcare professionals and patients suffering from allergic rhinitis. Secondary data is collected from online databases and published research papers.
The data analysis method for this research project is both qualitative and quantitative. Qualitative analysis is conducted through content analysis which involves analysis of data gathered through interviews and surveys. Quantitative analysis is conducted through trend analysis and involves analysis of the market trends and factors driving the growth of the market.
8. Ethical Considerations:
When conducting the research, ethical considerations are taken into account. These considerations include obtaining informed consent from the participants, maintaining privacy and confidentiality of the data, and avoiding any kind of manipulation or bias in the data collected.
9. Conclusion:
The research aims to provide a market analysis of the allergic rhinitis market over the forecast period of 2023-2030. The study uses a descriptive research design and collects data from both primary and secondary sources. Data analysis is conducted through qualitative and quantitative methods.
1 Executive Summary
1.1 MARKET SYNOPSIS 14
1.2 KEY CONTRIBUTING FACTORS 15
2 Market Introduction
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 17
2.5 ASSUMPTIONS & LIMITATIONS 17
3 RESEARCH METHODOLOGY
3.1 DATA MINING 18
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.3.1 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.4 FORECASTING TECHNIQUES 22
3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23
3.5.1 BOTTOM-UP APPROACH 24
3.5.2 TOP-DOWN APPROACH 24
3.5.3 DATA TRIANGULATION 25
3.5.4 VALIDATION 25
4 MARKET DYNAMICS
4.1 INTRODUCTION 26
4.2 DRIVERS 27
4.2.1 RISING PREVALENCE OF ALLERGIC RHINITIS 27
4.2.2 GOVERNMENT INITIATIVES TO CREATE AWARENESS 27
4.2.3 INCREASING HEALTHCARE EXPENDITURE 27
4.3 RESTRAINTS 28
4.3.1 PATENT EXPIRY 28
4.3.2 SIDE EFFECTS OF TREATMENT FOR ALLERGIC RHINITIS 28
4.4 OPPORTUNITIES 28
4.4.1 INCREASING DEMAND IN DEVELOPING COUNTRIES 28
4.4.2 MORE ADVANCED PRODUCTS 28
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29
5.1.1 BARGAINING POWER OF SUPPLIERS 30
5.1.2 BARGAINING POWER OF BUYERS 30
5.1.3 THREAT OF NEW ENTRANTS 30
5.1.4 THREAT OF SUBSTITUTES 30
5.1.5 INTENSITY OF RIVALRY 30
5.2 VALUE CHAIN ANALYSIS 31
5.2.1 R&D 32
5.2.2 MANUFACTURING 32
5.2.3 DISTRIBUTION & SALES 32
5.2.4 POST-SALES MONITORING 32
6 GLOBAL ALLERGIC RHINITIS MARKET BY TYPE
6.1 OVERVIEW 33
6.2 SEASONAL ALLERGIC RHINITIS 34
6.3 PERENNIAL ALLERGIC RHINITIS 34
6.4 OCCUPATIONAL ALLERGIC RHINITIS 35
7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT
7.1 INTRODUCTION 36
7.2 ANTIHISTAMINES 37
7.3 CORTICOSTEROIDS 37
7.4 DECONGESTANTS 38
7.5 IMMUNOTHERAPY 38
7.6 INTRANASAL ANTICHOLINERGICS 38
7.7 OTHERS 39
8 GLOBAL ALLERGIC RHINITIS MARKET BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW 40
8.2 NASAL 41
8.3 ORAL 41
8.4 OTHERS 42
9 GLOBAL ALLERGIC RHINITIS MARKET BY DISTRIBUTION CHANNEL
9.1 OVERVIEW 43
9.2 RETAIL PHARMACIES 44
9.3 HOSPITAL PHARMACIES 44
9.4 ONLINE STORES 45
10 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION
10.1 INTRODUCTION 46
10.2 AMERICAS 48
10.2.1 NORTH AMERICA 50
10.2.1.1 US 52
10.2.1.2 CANADA 53
10.2.2 LATIN AMERICA 54
10.2.2.1 BRAZIL 56
10.2.2.2 ARGENTINA 58
10.2.2.3 COLUMBIA 59
10.2.2.4 CHILE 60
10.2.2.5 REST OF LATIN AMERICA 62
10.3 EUROPE 64
10.3.1.1 WESTERN EUROPE 66
10.3.1.2 GERMANY 68
10.3.1.3 FRANCE 69
10.3.1.4 UK 70
10.3.1.5 ITALY 72
10.3.1.6 SPAIN 73
10.3.1.7 REST OF WESTERN EUROPE 74
10.3.1.8 EASTERN EUROPE 76
10.4 ASIA-PACIFIC 78
10.4.1.1 JAPAN 80
10.4.1.2 CHINA 81
10.4.1.3 INDIA 83
10.4.1.4 AUSTRALIA 84
10.4.1.5 SOUTH KOREA 85
10.4.1.6 THAILAND 87
10.4.1.7 REST OF ASIA-PACIFIC 88
10.5 MIDDLE EAST & AFRICA 90
10.5.1.1 MIDDLE EAST 92
10.5.1.2 AFRICA 93
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 95
12 COMPANY PROFILES
12.1 ASTRAZENECA 97
12.1.1 COMPANY OVERVIEW 97
12.1.2 FINANCIAL OVERVIEW 97
12.1.3 PRODUCTS/SERVICES OFFERED 98
12.1.4 KEY DEVELOPMENTS 98
12.1.5 SWOT ANALYSIS 99
12.1.6 KEY STRATEGIES 99
12.2 BOEHRINGER INGELHEIM 100
12.2.1 COMPANY OVERVIEW 100
12.2.2 FINANCIAL OVERVIEW 100
12.2.3 PRODUCTS/SERVICES OFFERED 101
12.2.4 KEY DEVELOPMENTS 101
12.2.5 SWOT ANALYSIS 102
12.2.6 KEY STRATEGIES 102
12.3 MERCK & CO., INC. 103
12.3.1 COMPANY OVERVIEW 103
12.3.2 FINANCIAL OVERVIEW 103
12.3.3 PRODUCTS/SERVICES OFFERED 104
12.3.4 KEY DEVELOPMENTS 104
12.3.5 SWOT ANALYSIS 105
12.3.6 KEY STRATEGIES 105
12.4 GLAXOSMITHKLINE PLC 106
12.4.1 COMPANY OVERVIEW 106
12.4.2 FINANCIAL OVERVIEW 106
12.4.3 PRODUCTS/SERVICES OFFERED 107
12.4.4 KEY DEVELOPMENTS 107
12.4.5 SWOT ANALYSIS 108
12.4.6 KEY STRATEGIES 108
12.5 JOHNSON & JOHNSON SERVICES, INC. 109
12.5.1 COMPANY OVERVIEW 109
12.5.2 FINANCIAL OVERVIEW 109
12.5.3 PRODUCTS/SERVICES OFFERED 110
12.5.4 KEY DEVELOPMENTS 110
12.5.5 SWOT ANALYSIS 111
12.5.6 KEY STRATEGIES 111
12.6 BAYER AG 112
12.6.1 COMPANY OVERVIEWS 112
12.6.2 FINANCIAL OVERVIEW 112
12.6.3 PRODUCTS/SERVICES OFFERED 113
12.6.4 KEY DEVELOPMENTS 113
12.6.5 SWOT ANALYSIS 114
12.6.6 KEY STRATEGIES 114
12.7 ALK-ABELLĂ“ A/S 115
12.7.1 COMPANY OVERVIEW 115
12.7.2 FINANCIAL OVERVIEW 115
12.7.3 PRODUCTS/SERVICES OFFERED 116
12.7.4 KEY DEVELOPMENTS 116
12.7.5 SWOT ANALYSIS 117
12.7.6 KEY STRATEGIES 117
12.8 MEDA PHARMACEUTICALS 118
12.8.1 COMPANY OVERVIEW 118
12.8.2 FINANCIAL OVERVIEW 118
12.8.3 PRODUCTS/SERVICES OFFERED 119
12.8.4 KEY DEVELOPMENTS 119
12.8.5 SWOT ANALYSIS 120
12.8.6 KEY STRATEGIES 120
12.9 SANOFI 121
12.9.1 COMPANY OVERVIEW 121
12.9.2 FINANCIAL OVERVIEW 121
12.9.3 PRODUCTS/SERVICES OFFERED 122
12.9.4 KEY DEVELOPMENTS 122
12.9.5 SWOT ANALYSIS 123
12.9.6 KEY STRATEGIES 123
12.10 NOVARTIS AG 124
12.10.1 COMPANY OVERVIEW 124
12.10.2 FINANCIAL OVERVIEW 124
12.10.3 PRODUCTS/SERVICES OFFERED 125
12.10.4 KEY DEVELOPMENTS 125
12.10.5 SWOT ANALYSIS 126
12.10.6 KEY STRATEGIES 126
13 APPENDIX
13.1 REFERENCES 127
13.2 RELATED REPORTS 127
14 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 17
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21
TABLE 3 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 34
TABLE 4 GLOBAL ALLERGIC RHINITIS MARKET FOR SEASONAL ALLERGIC RHINITIS, BY REGION, 2020–2027 (USD MILLION) 34
TABLE 5 GLOBAL ALLERGIC RHINITIS MARKET FOR PERENNIAL ALLERGIC RHINITIS, BY REGION, 2020–2027 (USD MILLION) 34
TABLE 6 GLOBAL ALLERGIC RHINITIS MARKET FOR OCCUPATIONAL ALLERGIC RHINITIS, BY REGION, 2020–2027 (USD MILLION) 35
TABLE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 37
TABLE 8 GLOBAL ALLERGIC RHINITIS MARKET FOR ANTIHISTAMINES, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 9 GLOBAL ALLERGIC RHINITIS MARKET FOR CORTICOSTEROIDS, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 10 GLOBAL ALLERGIC RHINITIS MARKET FOR DECONGESTANTS, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 11 GLOBAL ALLERGIC RHINITIS MARKET FOR IMMUNOTHERAPY, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 12 GLOBAL ALLERGIC RHINITIS MARKET FOR INTRANASAL ANTICHOLINERGICS, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 13 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 39
TABLE 14 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 41
TABLE 15 GLOBAL ALLERGIC RHINITIS MARKET FOR NASAL, BY REGION, 2020–2027 (USD MILLION) 41
TABLE 16 GLOBAL ALLERGIC RHINITIS MARKET FOR ORAL, BY REGION, 2020–2027 (USD MILLION) 41
TABLE 17 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER ROUTE OF ADMINISTRATION, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 18 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 44
TABLE 19 GLOBAL ALLERGIC RHINITIS MARKET FOR RETAIL PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 20 GLOBAL ALLERGIC RHINITIS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 21 GLOBAL ALLERGIC RHINITIS MARKET FOR ONLINE STORES, BY REGION, 2020–2027 (USD MILLION) 45
TABLE 22 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2020–2027 (USD MILLION) 47
TABLE 23 AMERICAS: ALLERGIC RHINITIS MARKET, BY REGION, 2020–2027 (USD MILLION) 48
TABLE 24 AMERICAS: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 48
TABLE 25 AMERICAS: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 49
TABLE 26 AMERICAS: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 49
TABLE 27 AMERICAS: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 49
TABLE 28 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50
TABLE 29 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 50
TABLE 30 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 51
TABLE 31 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 51
TABLE 32 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 51
TABLE 33 US: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 52
TABLE 34 US: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 52
TABLE 35 US: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 52
TABLE 36 US: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 53
TABLE 37 CANADA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 53
TABLE 38 CANADA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 53
TABLE 39 CANADA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 54
TABLE 40 CANADA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 54
TABLE 41 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55
TABLE 42 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 43 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 55
TABLE 44 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 56
TABLE 45 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 56
TABLE 46 BRAZIL: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 56
TABLE 47 BRAZIL: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 57
TABLE 48 BRAZIL: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 57
TABLE 49 BRAZIL: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 57
TABLE 50 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 58
TABLE 51 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 58
TABLE 52 ARGENTINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 58
TABLE 53 ARGENTINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 59
TABLE 54 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 59
TABLE 55 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 59
TABLE 56 COLUMBIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 60
TABLE 57 COLUMBIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 60
TABLE 58 CHILE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 60
TABLE 59 CHILE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 61
TABLE 60 CHILE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 61
TABLE 61 CHILE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 61
TABLE 62 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 63 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 62
TABLE 64 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 62
TABLE 65 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 63
TABLE 66 EUROPE: ALLERGIC RHINITIS MARKET, BY REGION, 2020–2027 (USD MILLION) 64
TABLE 67 EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 64
TABLE 68 EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 65
TABLE 69 EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 65
TABLE 70 EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 65
TABLE 71 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66
TABLE 72 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 73 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 67
TABLE 74 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 67
TABLE 75 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 67
TABLE 76 GERMANY: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 77 GERMANY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 68
TABLE 78 GERMANY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 68
TABLE 79 GERMANY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 69
TABLE 80 FRANCE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 81 FRANCE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 69
TABLE 82 FRANCE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 70
TABLE 83 FRANCE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 70
TABLE 84 UK: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 70
TABLE 85 UK: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 71
TABLE 86 UK: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 71
TABLE 87 UK: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 71
TABLE 88 ITALY: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 89 ITALY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 72
TABLE 90 ITALY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 72
TABLE 91 ITALY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 73
TABLE 92 SPAIN: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 93 SPAIN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 73
TABLE 94 SPAIN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 74
TABLE 95 SPAIN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 74
TABLE 96 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 97 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 75
TABLE 98 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 75
TABLE 99 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 75
TABLE 100 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 101 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 76
TABLE 102 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 76
TABLE 103 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 77
TABLE 104 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
TABLE 105 SIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 106 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 79
TABLE 107 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 79
TABLE 108 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 80
TABLE 109 JAPAN: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 110 JAPAN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 80
TABLE 111 JAPAN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 81
TABLE 112 JAPAN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 81
TABLE 113 CHINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 114 CHINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 82
TABLE 115 CHINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 82
TABLE 116 CHINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 82
TABLE 117 INDIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 118 INDIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 83
TABLE 119 INDIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 83
TABLE 120 INDIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 84
TABLE 121 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 122 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 84
TABLE 123 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 85
TABLE 124 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 85
TABLE 125 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 126 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 86
TABLE 127 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 86
TABLE 128 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 86
TABLE 129 THAILAND: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 87
TABLE 130 THAILAND: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 87
TABLE 131 THAILAND: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 87
TABLE 132 THAILAND: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 88
TABLE 133 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 134 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 88
TABLE 135 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 89
TABLE 136 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 89
TABLE 137 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY REGION, 2020–2027 (USD MILLION) 90
TABLE 138 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 139 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 91
TABLE 140 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 91
TABLE 141 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 91
TABLE 142 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 143 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 92
TABLE 144 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 92
TABLE 145 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 93
TABLE 146 AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 147 AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 93
TABLE 148 AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 94
TABLE 149 AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 94
TABLE 150 ASTRAZENECA: PRODUCTS/SERVICES OFFERED 98
TABLE 151 ASTRAZENECA: KEY DEVELOPMENTS 98
TABLE 152 BOEHRINGER INGELHEIM: PRODUCTS/SERVICES OFFERED 101
TABLE 153 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS 101
TABLE 154 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 104
TABLE 155 MERCK & CO., INC: KEY DEVELOPMENTS 104
TABLE 156 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 107
TABLE 157 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 107
TABLE 158 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES OFFERED 110
TABLE 159 BAYER AG: PRODUCTS/SERVICES OFFERED 113
TABLE 160 BAYER AG: KEY DEVELOPMENTS 113
TABLE 161 ALK-ABELLĂ“ A/S: PRODUCTS/SERVICES OFFERED 116
TABLE 162 ALK-ABELLĂ“ A/S: KEY DEVELOPMENTS 116
TABLE 163 MEDA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 119
TABLE 164 MEDA PHARMACEUTICALS: KEY DEVELOPMENTS 119
TABLE 165 SANOFI: PRODUCTS/SERVICES OFFERED 122
TABLE 166 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 125
15 List of Figures
FIGURE 1 MARKET SYNOPSIS 14
FIGURE 2 GLOBAL ALLERGIC RHINITIS MARKET: STRUCTURE 17
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 23
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET 26
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ALLERGIC RHINITIS MARKET 29
FIGURE 6 VALUE CHAIN ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET 31
FIGURE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 33
FIGURE 8 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION) 36
FIGURE 9 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2027 (USD MILLION) 40
FIGURE 10 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION) 43
FIGURE 11 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 47
FIGURE 12 AMERICAS: ALLERGIC RHINITIS MARKET SHARE, BY REGION 2020 (%) 48
FIGURE 13 NORTH AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2020 (%) 50
FIGURE 14 LATIN AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2020 (%) 54
FIGURE 15 EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2020 (%) 64
FIGURE 16 WESTERN EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2020 (%) 66
FIGURE 17 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2020 (%) 78
FIGURE 18 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2020 (%) 90
FIGURE 19 GLOBAL ALLERGIC RHINITIS MARKET, MARKET SHARE ANALYSIS 2020 (% SHARE) 95
FIGURE 20 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT 97
FIGURE 21 ASTRAZENECA: SWOT ANALYSIS 99
FIGURE 22 BOEHRINGER INGELHEIM: FINANCIAL OVERVIEW 100
FIGURE 23 BOEHRINGER INGELHEIM: SWOT ANALYSIS 102
FIGURE 24 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 25 MERCK & CO., INC.: SWOT ANALYSIS 105
FIGURE 26 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 106
FIGURE 27 GLAXOSMITHKLINE PLC.: SWOT ANALYSIS 108
FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 109
FIGURE 29 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS 111
FIGURE 30 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 112
FIGURE 31 BAYER AG: SWOT ANALYSIS 114
FIGURE 32 ALK-ABELLĂ“ A/S FINANCIAL OVERVIEW SNAPSHOT 115
FIGURE 33 ALK-ABELLĂ“ A/S: SWOT ANALYSIS 117
FIGURE 34 MEDA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT 118
FIGURE 35 MEDA PHARMACEUTICALS: SWOT ANALYSIS 120
FIGURE 36 SANOFI: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 37 SANOFI: SWOT ANALYSIS 123
FIGURE 38 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 124
FIGURE 39 NOVARTIS AG: SWOT ANALYSIS 126
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
